Farmak discovers and delivers innovative medicines and solutions that enhance people’s lives.
We continually expand our market presence in well-regulated and emerging markets by developing and producing high-quality products and maintaining a robust business reputation.
Enteric-сoated Tablets
400mg
Film-coated Tablets
100mg, 200mg
100mg+100mg
Capsule soft oral
20 000 IE
Unit Dose Powder for oral Suspension Sachet
3.76g
10mg
Solution for Injection
5mg/mL: 0.5mL, 1mL, 2mL
Capsules solid
275.1mg+50mg
50mg+50mg
Unit Dose Powder Granules for oral Solution Sachet Conc. for Infusion Solution
3g/5g
500mg/mL: 10mL
Unit Dose Liquid Solution for oral use
1000mg + 1000mg: 10mL
Unit Dose Powder for oral Solution Sachet
64g/73.69g
Capsules solid (XR) Film-coated Tablets
200mg
135mg
Tablets prolong. action (XR)
1200mg
10mg, 20mg, 40mg
50mg/mL: 5mL
Drops oral Solution Tablets
0.75%: 15mL, 25mL, 30mL
5mg, 7.5mg
250mg, 500mg
Conc. for Solution for Infusion
Ampoule Vit. B1, B2, B6 + Ampoule Vit. C, Nicotinamide, Glucose Instruction
50mg/mL+50mg/mL+0.5mg/mL: 2mL
10mg, 20mg
Farmak International offers a range of high-quality and affordable healthcare products supported by extensive expertise across 14 therapeutic areas, including the alimentary tract and metabolism.
We offer a range of digestive system pharmaceuticals for key organs, such as the stomach and the intestines. The range can also be helpful for patients who complain about the pathways through which food is delivered to the body, such as the mouth or the gullet.
Also, this production class includes metabolic disorder medications that are administered when lifestyle changes and diets are not sufficient to enhance the body’s ability to break down, process, or distribute proteins, carbohydrates, and fats.
Whether the above disorders are inborn or acquired, our medications can impact abnormal chemical reactions in the body and help a patient feel better.
This pharmaceutical category ranges a wide array of medications for relevant healthcare needs, including H2 receptor antagonists, proton pump inhibitors, and others. We have our own production and research and development facilities with advanced quality control located in Ukraine and Spain.
The product range includes medicines used primarily to treat:
There are vitamins to treat and manage peripheral neuropathy, protect nerves, and more, such as vitamin D3 (Cholecalciferol), B6, B1 (Benfothiaminum), B2, B12, ascorbic acid, nicotinamide, and glucose. We produce drugs to improve lipid metabolism, such as Phosphatidylcholine from soybeans. Also, we are a laxative distributor.
The above drugs are proven effective by regulatory bodies and intended for hospital supply. The quality is checked in our laboratories by testing methods approved by leading pharmacopoeias. That is why we are well positioned to be awarded long-term institutional procurement contracts to distribute drugs to healthcare facilities.
Our products are intended for use within controlled medical facilities. We distribute them to pharmaceutical companies, distributors, hospitals, procurement organizations, and healthcare partners. We always adhere to strict regulatory guidelines on sterile compounding and institutional safety. We prepare CTD dossiers with overviews of how drugs are made and tested to submit to regulatory agencies and obtain drug approvals required for marketing internationally.
Farmak Group manufactures generic gastrointestinal drugs for intensive care and MRI & CT diagnostics, long-acting injectables, peptides, etc. Our products from this category are primarily indicated for managing diseases and symptoms related to the digestive tract, liver, and pancreas.
As a gastrointestinal drugs supplier, Farmak Group ensures the formulation’s physical and chemical parameters, provides well-packaged goods, and uses climate-controlled logistics to ensure the proper delivery conditions so that drugs remain stable.
We offer film-coated tablets, granules, solid capsules, sachets with powder, solutions for injections, concentrates for solution for infusions, and oral drops solutions for various routes of delivery. All these formulations define various speeds of action and bioavailability.
Some components are destroyed by stomach acid or the liver before reaching the target. Others are intended for specific fat deposits or rapid medical intervention. That is why they are taken in a way to bypass the digestive tract. If there are no restrictions, the central route remains the most convenient. It enhances patient adherence to treatment schedules.
We tailor packaging to the drug’s physical state. Tablets are packed in unit-dose blisters. Injectables come in glass ampules or containers. Powders are dosed in sachets.
Products stored in their sealed packages away from heat, light, and moisture. The specific temperature regime is required. For complete, exact guidelines on handling, you should turn to our managers.
Farmak International delivers high quality in every product to comply with global regulatory authorities. Quality assurance and regulatory compliance are integrated into every stage of product development and manufacturing rather than treated as separate checkpoints. This approach helps ensure consistent product performance, maintains high quality standards, and supports compliance with regulatory requirements across international distribution networks.
A GMP (Good Manufacturing Practice) certificate ensures drugs are consistently produced and meet rigorous safety and quality requirements. Our EU GMP-certified manufacturing is a guarantee of safe and effective medicines, free of contamination.
Regulatory approvals from the European Medicines Agency (EMA) and local authorities are critical for drug manufacturers as they permit them to legally access markets. They build clinical trust so that medicines are delivered to hospitals.
Our drugs and ingredients are made to meet the minimum chemical and physical quality standards of the region they are delivered to. We guarantee the standardised purity of our products, approved by local commissions.
At Farmak International, we ensure a reliable supply chain thanks to our efficient logistics, making our products available across the globe. We offer a full-cycle cooperation model through licensing partnerships, distribution partnerships, hospital tender participation. We can boast successful launches in over 60 countries.
Our partners benefit from the following:
Our team ensures that our products and services meet the highest quality standards.
Our lead time includes raw material procurement, production, packaging, quality control, and testing, which is typically constant. Final delivery takes different times depending on the logistics.
To place an order or consult on our products and partnership terms, please send your inquiry to bd@farmak.ch. We’ll respond to discuss a partnership. For personal, real-time communication, you can reach out to our team by phone: +41 41 541 0268.
This information is intended solely for healthcare professionals. Healthcare professionals must rely on their own professional clinical judgment when deciding whether to use a particular product for treating a specific patient. Farmak AG does not provide medical advice and recommends that healthcare professionals be appropriately trained in the use of any product before administering it. Healthcare professionals must always refer to the product's package insert, label, and/or instructions for use before application. The information provided is intended to illustrate Farmak AG's product portfolio and may vary depending on regulatory or medical practices in different markets. Please contact your local Farmak International representative for availability information about specific products in your area.
This page is designed exclusively for healthcare professionals. If you are not a healthcare professional, please return to our homepage for general information about Farmak International.
Please check your email inbox for our corporate materials.
Please fill all the fields marked by *